Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health
Abstract
:1. Introduction
2. Methods
2.1. Data
2.2. Measures
2.2.1. MS
2.2.2. Mental Health
2.2.3. Demographic Controls
2.3. Analysis
2.3.1. Factor Model
2.3.2. Linear Model
3. Results
4. Discussion
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- National MS Society. MS Symptoms 2020. Available online: https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms (accessed on 16 September 2022).
- Parker, L.S.; Topcu, G.; De Boos, D.; das Nair, R. The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: A systematic meta-synthesis. Disabil. Rehabil. 2021, 43, 3276–3290. [Google Scholar] [CrossRef] [PubMed]
- White, C.P.; White, M.B.; Russell, C.S. Invisible and visible symptoms of multiple sclerosis: Which are more predictive of health distress? J. Neurosci. Nurs. 2008, 40, 85–95. [Google Scholar] [CrossRef] [PubMed]
- Davis, B.E.; Lakin, L.; Binns, C.C.; Currie, K.M.; Rensel, M.R. Patient and provider insights into the impact of multiple sclerosis on mental health: A narrative review. Neurol. Ther. 2021, 10, 99–119. [Google Scholar] [CrossRef] [PubMed]
- Lakin, L.; Davis, B.E.; Binns, C.C.; Currie, K.M.; Rensel, M.R. Comprehensive approach to management of multiple sclerosis: Addressing invisible symptoms—A narrative review. Neurol. Ther. 2021, 10, 75–98. [Google Scholar] [CrossRef]
- Rieckmann, P.; Centonze, D.; Elovaara, I.; Giovannoni, G.; Havrdová, E.; Kesselring, J.; Ben-Amor, A.F. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st century steering group. Mult. Scler. Relat. Disord. 2018, 19, 153–160. [Google Scholar] [CrossRef] [Green Version]
- Murphy, R.; O’Donoghue, S.; Counihan, T.; McDonald, C.; Calabresi, P.A.; Ahmed, M.A.; Hallahan, B. Neuropsychiatric syndromes of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2017, 88, 697–708. [Google Scholar] [CrossRef]
- Silveira, C.; Guedes, R.; Maia, D.; Curral, R.; Coelho, R. Neuropsychiatric symptoms of multiple sclerosis: State of the art. Psychiatry Investig. 2019, 16, 877. [Google Scholar] [CrossRef]
- Jun-O’Connell, A.H.; Butala, A.; Morales, I.B.; Henninger, N.; Deligiannidis, K.M.; Byatt, N.; Ionete, C. The prevalence of bipolar disorders and association with quality of life in a cohort of patients with multiple sclerosis. J. Neuropsychiatry Clin. Neurosci. 2017, 29, 45–51. [Google Scholar] [CrossRef] [Green Version]
- Gill, S.; Santo, J.; Blair, M.; Morrow, S.A. Depressive symptoms are associated with more negative functional outcomes than anxiety symptoms in persons with multiple sclerosis. J. Neuropsychiatry Clin. Neurosci. 2019, 31, 37–42. [Google Scholar] [CrossRef]
- McKay, K.A.; Tremlett, H.; Fisk, J.D.; Zhang, T.; Patten, S.B.; Kastrukoff, L.; Marrie, R.A. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology 2018, 90, e1316–e1323. [Google Scholar] [CrossRef]
- Mitchell, A.J.; Benito-León, J.; González, J.M.M.; Rivera-Navarro, J. Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurol. 2005, 4, 556–566. [Google Scholar] [CrossRef]
- Mohr, D.C.; Hart, S.L.; Fonareva, I.; Tasch, E.S. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult. Scler. J. 2006, 12, 204–208. [Google Scholar] [CrossRef] [PubMed]
- Raissi, A.; Bulloch, A.G.; Fiest, K.M.; McDonald, K.; Jetté, N.; Patten, S.B. Exploration of undertreatment and patterns of treatment of depression in multiple sclerosis. Int. J. MS Care 2015, 17, 292–300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goldberg, D.; Williams, P. A User’s Guide to the General Health Questionnaire; NFER-NELSON: Windsor, ON, USA, 1988. [Google Scholar]
- El-Metwally, A.; Javed, S.; Razzak, H.A.; Aldossari, K.K.; Aldiab, A.; Al-Ghamdi, S.H.; Al-Zahrani, J.M. The factor structure of the general health questionnaire (GHQ12) in Saudi Arabia. BMC Health Serv. Res. 2018, 18, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Fernandes, H.M.; Vasconcelos-Raposo, J. Factorial validity and invariance of the GHQ-12 among clinical and nonclinical samples. Assessment 2012, 20, 219–229. [Google Scholar] [CrossRef]
- Hankins, M. The factor structure of the twelve-item general health questionnaire (GHQ-12): The result of negative phrasing? Clin. Pract. Epidemiol. Ment. Health 2008, 4, 10. [Google Scholar] [CrossRef] [Green Version]
- López, M.P.S.; Dresch, V. The 12-item general health questionnaire (GHQ-12): Reliability, external validity and factor structure in the Spanish population. Psicothema 2008, 20, 839–843. [Google Scholar]
- Salama-Younes, M.; Montazeri, A.; Ismaïl, A.; Roncin, C. Factor structure and internal consistency of the 12-item general health questionnaire (GHQ-12) and the subjective vitality scale (VS), and the relationship between them: A study from France. Health Qual. Life Outcomes 2009, 7, 1. [Google Scholar] [CrossRef] [Green Version]
- Smith, A.B.; Fallowfield, L.J.; Stark, D.P.; Velikova, G.; Jenkins, V.A. Rasch and confirmatory factor analysis of the general health questionnaire (GHQ)-12. Health Qual. Life Outcomes 2010, 8, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Daradkeh, T.K.; Ghubash, R.; ElRufaie, O.E.F. Reliability, validity, and factor structure of the Arabic version of the 12-item general health questionnaire. Psychol. Rep. 2001, 89, 85–94. [Google Scholar] [CrossRef]
- Endsley, P.; Weobong, B.; Nadkarni, A. The psychometric properties of GHQ for detecting common mental disorder among community dwelling men in Goa, India. Asian. J. Psychiatr. 2017, 28, 106–110. [Google Scholar] [CrossRef] [PubMed]
- Graetz, B. Multidimensional properties of the general health questionnaire. Soc. Psychiatry Psychiatr. Epidemiol. 1991, 26, 132–138. [Google Scholar] [CrossRef] [PubMed]
- Campbell, A.; Knowles, S. A confirmatory factor analysis of the GHQ12 using a large Australian sample. Eur. J. Psychol. Assess. 2007, 23, 2–8. [Google Scholar] [CrossRef]
- Padrón, A.; Galán, I.; Durbán, M.; Gandarillas, A. Confirmatory factor analysis of the general health questionnaire (GHQ-12) in Spanish adolescents. Qual. Life Res. 2012, 21, 1291–1298. [Google Scholar] [CrossRef]
- Penninkilampi-Kerola, V.; Miettunen, J.; Ebeling, H. Health and disability: A comparative assessment of the factor structures and psychometric properties of the GHQ-12 and the GHQ-20 based on data from a Finnish population-based sample. Scand. J. Psychol. 2006, 47, 431–440. [Google Scholar] [CrossRef]
- Gao, W.; Stark, D.; Bennett, M.I.; Siegert, R.J.; Murray, S.; Higginson, I.J. Using the 12-item general health questionnaire to screen psychological distress from survivorship to end-of-life care: Dimensionality and item quality. Psycho-Oncology 2012, 21, 954–961. [Google Scholar] [CrossRef]
- Marsh, H.W.; Morin, A.J.; Parker, P.D.; Kaur, G. Exploratory structural equation modeling: An integration of the best features of exploratory and confirmatory factor analysis. Annu. Rev. Clin. Psychol. 2014, 10, 85–110. [Google Scholar] [CrossRef] [Green Version]
- Griffith, G.J.; Jones, K. Understanding the population structure of the GHQ-12: Methodological considerations in dimensionally complex measurement outcomes. Soc. Sci. Med. 2019, 243, 112638. [Google Scholar] [CrossRef]
- University of Essex, Institute for Social and Economic Research. Understanding Society: Waves 1–11, 2009–2020 and Harmonised BHPS: Waves 1–18, 1991–2009, 15th ed.; UK Data Service, 2022; SN: 6614. [data collection]; Available online: https://doi.org/10.5255/UKDA-SN-6614-16 (accessed on 25 September 2022).
- Gupta, S.; Goren, A.; Phillips, A.L.; Dangond, F.; Stewart, M. Self-reported severity among patients with multiple sclerosis in the US and its association with health outcomes. Mult. Scler. Relat. Disord. 2014, 3, 78–88. [Google Scholar] [CrossRef]
- Le, H.H.; Ken-Opurum, J.; LaPrade, A.; Maculaitis, M.C.; Sheehan, J.J. Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey data. Mult. Scler. Relat. Disord. 2022, 65, 103971. [Google Scholar] [CrossRef]
- Rajabi, G.; Sheykhshabani, S.H. Factor structure of the 12-item general health questionnaire. J. Educ. Psychol. 2009, 3, 81–94. [Google Scholar]
- Foley, F.; Sarnoff, J. Taming Stress in Multiple Sclerosis [Brochure]. 2016. Retreived from: National MS Society. Available online: https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/Brochure-Taming-Stress.pdf (accessed on 12 July 2022).
- Ross, A.; Weigel, M. What is the role of stress in multiple sclerosis? Couns Points 2016, 11, 4–12. [Google Scholar]
- Boeschoten, R.E.; Braamse, A.M.; Beekman, A.T.; Cuijpers, P.; van Oppen, P.; Dekker, J.; Uitdehaag, B.M. Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis. J. Neurol. Sci. 2017, 372, 331–341. [Google Scholar] [CrossRef]
- Hanna, M.; Strober, L.B. Anxiety and depression in multiple sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life. Mult. Scler. Relat. Disord. 2020, 44, 102261. [Google Scholar] [CrossRef]
- Rossi, S.; Studer, V.; Motta, C.; Polidoro, S.; Perugini, J.; Macchiarulo, G.; Centonze, D. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology 2017, 89, 1338–1347. [Google Scholar] [CrossRef] [PubMed]
- Briones-Buixassa, L.; Milà, R.; Mª Aragonès, J.; Bufill, E.; Olaya, B.; Arrufat, F.X. Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress. Health Psychol. Open 2015, 2, 2055102915612271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mohr, D.C.; Hart, S.L.; Julian, L.; Cox, D.; Pelletier, D. Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis. Bmj 2004, 328, 731. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mohr, D.C.; Pelletier, D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav. Immun. 2006, 20, 27–36. [Google Scholar] [CrossRef] [PubMed]
Healthy Controls | MS Patients | |||
---|---|---|---|---|
Mean | S.D. | Mean | S.D. | |
Age | 49.10 | 18.24 | 52.19 | 12.94 |
Monthly income | 1642.32 | 1502.97 | 1490.91 | 875.54 |
N | % | N | % | |
Sex | ||||
Male | 11,685 | 44.27 | 20 | 25.64 |
Female | 14,709 | 55.73 | 58 | 74.36 |
Highest educational qualification | ||||
Below college | 16,787 | 63.60 | 42 | 53.85 |
College | 9607 | 36.40 | 36 | 46.15 |
Legal marital status | ||||
Single | 18,950 | 49.20 | 41 | 52.56 |
Married | 19,566 | 50.80 | 37 | 47.44 |
Residence | ||||
Urban | 30,110 | 78.18 | 57 | 73.08 |
Rural | 8406 | 21.82 | 21 | 26.92 |
GHQ-12 Items | GHQ-12A (Social Dysfunction and Anhedonia; 6 Items) | GHQ-12B (Depression and Anxiety; 4 Items) | GHQ-12C (Loss of Confidence; 2 Items) |
---|---|---|---|
Concentration | 0.53 | 0.25 | −0.10 |
Loss of sleep | 0.00 | 0.66 | 0.05 |
Playing a useful role | 0.67 | −0.16 | 0.16 |
Constantly under strain | 0.79 | −0.14 | 0.00 |
Problem overcoming difficulties | −0.01 | 0.88 | −0.07 |
Unhappy or depressed | 0.08 | 0.56 | 0.21 |
Losing confidence | 0.68 | 0.22 | −0.15 |
Believe worthless | 0.71 | −0.03 | 0.04 |
General happiness | 0.03 | 0.53 | 0.34 |
Capable of making decisions | 0.00 | 0.23 | 0.70 |
Ability to face problems | 0.10 | 0.02 | 0.74 |
Enjoy day-to-day activities | 0.56 | 0.10 | 0.10 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kang, W. Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health. J. Clin. Med. 2022, 11, 7483. https://doi.org/10.3390/jcm11247483
Kang W. Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health. Journal of Clinical Medicine. 2022; 11(24):7483. https://doi.org/10.3390/jcm11247483
Chicago/Turabian StyleKang, Weixi. 2022. "Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health" Journal of Clinical Medicine 11, no. 24: 7483. https://doi.org/10.3390/jcm11247483
APA StyleKang, W. (2022). Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health. Journal of Clinical Medicine, 11(24), 7483. https://doi.org/10.3390/jcm11247483